Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Cruickshank

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Indian Heart Journal|December 25, 2010
Beta-blockers and heart failureJohn M Cruickshank
Lancet (London, England)|August 10, 2010
Beta blockers in hypertensionJohn M Cruickshank
The American Journal of Managed Care|January 19, 2013
Evolving strategies for optimal care management and plan benefit designsJohn M Cruickshank
BMJ (Clinical Research Ed.)|October 14, 2011
Don't beta blockers still have a role in hypertension?John M Cruickshank
Advances in Experimental Medicine and Biology|December 14, 2016
The Role of Beta-Blockers in the Treatment of HypertensionJohn M Cruickshank
The New England Journal of Medicine|January 28, 2009
Follow-up of intensive glucose control in type 2 diabetesJohn M Cruickshank
Lancet (London, England)|January 24, 2006
Beta blockers for the treatment of primary hypertensionJohn M Cruickshank
The Journal of the American Osteopathic Association|May 20, 2011
Achieving cholesterol targets: how well are we doing?John M Cruickshank
International Journal of Cardiology|May 20, 2014
Hypertensive subjects with type-2 diabetes, the sympathetic nervous system, and treatment implicationsAndrew J S Coats, John M Cruickshank
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Indian Heart Journal|December 25, 2010
Beta-blockers and heart failureJohn M Cruickshank
Lancet (London, England)|August 10, 2010
Beta blockers in hypertensionJohn M Cruickshank
The American Journal of Managed Care|January 19, 2013
Evolving strategies for optimal care management and plan benefit designsJohn M Cruickshank
BMJ (Clinical Research Ed.)|October 14, 2011
Don't beta blockers still have a role in hypertension?John M Cruickshank
Advances in Experimental Medicine and Biology|December 14, 2016
The Role of Beta-Blockers in the Treatment of HypertensionJohn M Cruickshank
The New England Journal of Medicine|January 28, 2009
Follow-up of intensive glucose control in type 2 diabetesJohn M Cruickshank
Lancet (London, England)|January 24, 2006
Beta blockers for the treatment of primary hypertensionJohn M Cruickshank
The Journal of the American Osteopathic Association|May 20, 2011
Achieving cholesterol targets: how well are we doing?John M Cruickshank
International Journal of Cardiology|May 20, 2014
Hypertensive subjects with type-2 diabetes, the sympathetic nervous system, and treatment implicationsAndrew J S Coats, John M Cruickshank
Pageof 1